Evidence map›Paper›PMID 28104701›Full record

ArticleHaematologica2017

Prospective study of thrombosis and thrombospondin-1 expression in Chuvash polycythemia.

Adelina Sergueeva, Galina Miasnikova, Binal N Shah, Jihyun Song, Ekaterina Lisina, Daniel J Okhotin, Mehdi Nouraie, Sergei Nekhai, Tatiana Ammosova, Xiao Mei Niu and 3 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Adelina SergueevaI. N. Ulianov Chuvash State University, Cheboksary, Russia.
Galina MiasnikovaChuvash Republic Clinical Hospital, Cheboksary, Russia.
Binal N ShahDepartment of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, IL, USA.
Jihyun SongHematology Division, University of Utah School of Medicine, Salt Lake City, UT, USA.
Ekaterina LisinaFederal North-West Medical Research Center, St. Petersburg, Russia.
Daniel J OkhotinRussian Research Services, Vancouver, WA, USA.
Mehdi NouraieDepartment of Medicine, University of Pittsburgh, PA, USA.
Sergei NekhaiCenter For Sickle Cell Disease, Howard University, Washington DC, MD, USA.
Tatiana AmmosovaCenter For Sickle Cell Disease, Howard University, Washington DC, MD, USA.
Xiao Mei NiuCenter For Sickle Cell Disease, Howard University, Washington DC, MD, USA.
Josef T PrchalHematology Division, University of Utah School of Medicine, Salt Lake City, UT, USA.
Xu ZhangDepartment of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, IL, USA.
Victor R GordeukDepartment of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, IL, USA vgordeuk@uic.edu.
Howard University · USUniversity of Illinois Chicago · USChuvash State University · RUUniversity of Utah · USNorth-West Public Health Research Center · RUUniversity of Pittsburgh · US

Funding

Tissue BankP01CA108671 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ronald Hoffman · 2006 to 2026
$82.0M
PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
Center for Hemoglobin Research in Minorities (CHaRM)P50HL118006 · NHLBI · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2013 to 2017
$7.0M
Sickle Cell Disease and Sickle Cell Trait Protection Against HIV-1-infection in Africans and African AmericansR01HL125005 · NHLBI · HOWARD UNIVERSITY · PI MARINA A JEREBTSOVA, SERGEI NEKHAI · 2014 to 2026
$6.7M
NCI NIH HHS P01 CA108671NHLBI NIH HHS P50 HL118006NHLBI NIH HHS R01 HL125005NHLBI NIH HHS T32 HL007576NIMHD NIH HHS G12 MD007597
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene ExpressionAdultAgedAged, 80 and overBiomarkersCase-Control StudiesFemaleFollow-Up StudiesGerm-Line MutationHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitIncidenceMaleMiddle AgedPolycythemiaBiomarkersHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitThrombospondin 1Von Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID28104701
PMCPMC5477617
OpenAlexW2575526823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.